uFSH诱导耐氯米芬多囊卵巢综合征患者排卵效果观察被引量：1

Observation on the effect of inducing ovulation in patients with clomiphene-rsistant polycysic ovary syndrome by using urofolitropin.

下载PDF

导出

摘要目的评估使用国产尿促卵泡素(uFSH)低剂量缓增方案诱导耐氯米芬(CC)多囊卵巢综合征(PCOS)患者排卵的有效性和安全性。方法对18例耐CC的PCOS不孕症患者进行42个周期低剂量FSH缓增方案促排卵治疗,以阴道B超和血雌二醇(E2)水平作为监测卵泡发育的指标。结果有2例患者因多个卵泡发育、卵泡持续不长而中止治疗外,其余周期均出现排卵,其中23个周期为单卵泡发育。7例患者为单胎妊娠,2例双胎妊娠。结论使用国产uFSH低剂量缓增方案是治疗耐CC的PCOS无排卵患者有效而安全的治疗选择。根据阴道B超检查和血E2监测结果,适时调整药物剂量,是防止OHSS发生的有效措施。

作者汤本才李淑华杨霞

机构地区攀枝花市攀钢总医院生殖医学中心

出处《中国热带医学》 CAS 2007年第5期834-835,共2页 China Tropical Medicine

关键词不育女性尿促卵泡素(uFSH) 多囊卵巢综合征氯米芬

分类号 R711.6 [医药卫生—妇产科学]

引文网络
相关文献

参考文献7

1林守清.Yen & Jaffe生殖内分泌学[M].北京:人民卫生出版社,2006,592.
2The Rotterdam ESHRE/ASRM-Sponsored PCOS Workshop Group.Revised 2003 consansus on diagnostic criteria and longterm health risk related to polycystic ovary syndrome[J].Fertile Steri1,2004,81 (1):19.
3邓成艳,苏珊.重组基因的促卵泡生长素诱导多囊卵巢综合征患者排卵的临床分析[J].中华妇产科杂志,2003,38(1):37-39. 被引量：8
4Willis DS,Watson H,Mason H,et al.Premature tesponse to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome:relevance to mechanism of anovulation[J].Clin Endocrinol Metab,1998,83:3984 ～ 3991.
5Almahbobi G,Misajon A,Hutchinson P,et al.Hycrexpression of epidermal growth factor receptors in granulose cell from women with polycystic ovaries[J].Fertil Steril,1998,70:750 ～ 758.
6Hakan Y,Bülent OY,Aygül D,et al.Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome:a prospective randomized trial[J].Human Reproduction,2002,17(2):289 ～ 294.
7陈蔚琳,张以文,戴晴,张德永.促卵泡激素低剂量缓增方案治疗耐氯米芬多囊卵巢综合征无排卵不孕症[J].中华妇产科杂志,2000,35(10):588-590. 被引量：18

二级参考文献9

1Juan Balasch,Francisco Fábregues,Montserrat Creus,Roser Casamitjana,Bienvenido Puerto,Juan A. Vanrell. Recombinant Human Follicle-Stimulating Hormone for Ovulation Induction in Polycystic Ovary Syndrome: A Prospective, Randomized Trial Of Two Starting Doses in a Chronic Low-Dose Step-up Protocol[J] 2000,Journal of Assisted Reproduction and Genetics(10):561～565
2WhiteDM,PolsonDM,KiddyD ,etal.Inductionofovulationwithlowdosegonadotropininpolycysticovarysyndrome :aanalysisof 10 9pregnanciesin 2 2 5women[].JClinEndocrinolMetab.1996
3Brown JB.Pituitary control of ovarian function, concepts derived from gonadotropin therapy[].Australian and New Zealand Journal of Obstetrics and Gynaecology.1978
4Shoham Z,Paltel A,Jacobs HS.Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified folliclestimulating hormone[].Fertility and Sterility.1991
5Coelingh-Bennik H,Fauser B,Out HJ.Recombinant follicular stimulating hormone (Puregon) is more efficient than urinary follicular stimulating hormone (Metrodin ) in women with clomiphene citritrate resistant,normogonadotropic, chronic anovulation: a prospective, multicenter,assessor-blind[].Fertility and Sterility.1998
6Schoemaker J,Van Werssenbruch MM,Vander Meer M.New approaches with the FSH threshold principle in polycystic ovarian syndrome[].Annals of the New York Academy of Sciences.1993
7Aboulghar MA,Mansour RT,Serour GL,et al.Recombinant follicle stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome[].Fertility and Sterility.1996
8Grigorion O,Antomiou G,Antonaki V,et al.Low-dose follicle stimulating hormone treatment for polycystic ovarian disease[].International Journal of Gynecology and Obstetrics.1996
9Herman A,Ron-Ei R,Golan A,et al.Over stimulated cycles under lowdose gonadotropin in patients with polycystic ovary syndrome:characterization and management[].Human Reproduction.1993